SCHEMBL7025969

SCHEMBL7025969

COc1ccc(COC2=CC=CC[CH]2)cc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
APP P05067 7/20 0.46
MAOB P27338 1/20 0.45
IDO1 P14902 2/20 0.43
AGXT P21549 2/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FFAR1 O14842 1/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
ABCB1 P08183 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694567 0.80 LMNA (0.39) MAOBIDO1AGXTRAB9ASMN1; SMN2
SCHEMBL20000873 0.71 APP (0.80) APPMAOBIDO1AGXTNPC1
SCHEMBL4639726 0.70
SCHEMBL7373886 0.69 NR5A1 (0.35) NPC1RAB9AALDH1A1
SCHEMBL8077148 0.66 IDO1 (0.61) APPMAOBIDO1AGXTNPC1
SCHEMBL1853891 0.66 IDO1 (0.61) APPMAOBIDO1AGXTNPC1
SCHEMBL18475585 0.65 APP (0.69) APPMAOBNPC1RAB9APOLB
SCHEMBL171857 0.65 APP (0.69) APPMAOBNPC1RAB9APOLB
SCHEMBL13977985 0.65 APP (0.69) APPMAOBIDO1AGXTNPC1
SCHEMBL13952163 0.65 APP (0.69) APPMAOBIDO1AGXTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326856-A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-BETA) INHIBITING ACTIVITY Bayer Aktiengesellschaft (DE) 2003-07-16 EP disclosed
WO-2002024651-A1 A PROCESS FOR PRODUCING 2-AMINO-4,6-DISUBSTITUTED NICOTINIC ACID ESTER ANALOGS BAYER AKTIENGESELLSCHAFT (DE) 2002-03-28 WO disclosed
WO-2002024679-A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 2002-03-28 WO disclosed